US Stock MarketDetailed Quotes

ATYR aTyr Pharma

Watchlist
  • 1.510
  • -0.030-1.95%
Close Jul 5 16:00 ET
  • 1.490
  • -0.020-1.32%
Post 19:57 ET
104.21MMarket Cap-1715P/E (TTM)

About aTyr Pharma Company

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.

Company Profile

SymbolATYR
Company NameaTyr Pharma
Listing DateMay 7, 2015
Founded2005
CEODr. Sanjay S. Shukla, M.D.,M.S.
MarketNASDAQ
Employees59
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address10240 Sorrento Valley Road,Suite 300
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-731-8389
Websitehttp://www.atyrpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Sanjay S. Shukla, M.D.,M.S.
  • Director, President and Chief Executive Officer
  • 1.30M
  • Jill M. Broadfoot
  • Chief Financial Officer and Principal Accounting Officer
  • 677.84K
  • John K. Clarke
  • Chairman of the Board
  • 120.84K
  • Timothy P. Coughlin
  • Independent Director
  • 92.20K
  • Dr. Sara Zaknoen, M.D.
  • Independent Director
  • 66.88K
  • Dr. Paul R. Schimmel,PhD
  • Independent Director
  • 61.20K
  • Jane A. Gross
  • Independent Director
  • 68.88K
  • Dr. Svetlana Lucas, PhD
  • Independent Director
  • 73.20K
  • Nancy E. Denyes
  • General Counsel and Corporate Secretary
  • 651.28K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg